[Skip to Content]
[Skip to Content Landing]
December 1991

The Effects of Subconjunctival Mitomycin-C on Glaucoma Filtration Surgery in Rabbits

Arch Ophthalmol. 1991;109(12):1725-1730. doi:10.1001/archopht.1991.01080120109038

• A prospective, randomized, masked, placebo-controlled study was performed to determine whether a single, intraoperative subconjunctival application of a 0.5-mg/mL solution of mitomycin-C enhances the success of full-thickness filtration surgery in rabbits. Compared with control eyes, mitomycin-C-treated eyes showed significant increases in bleb duration from 8.1±2.4 to 68.0±20.8 days and in intraocular pressure reduction from 6.0±3.0 to 63.6±21.5 days. Histopathologic evaluation confirmed the inhibitory effects of mitomycin-C on fibrovascular, fibrocellular, and collagenous organization of the filtering blebs that resulted in their preservation. Transient, superficial, corneal vascularization anterior to the bleb occurred in all mitomycin-C-treated eyes. No other clinical or pathologic signs of undesirable side effects were noted. We studied the effectiveness and safety of a single intraoperative application of mitomycin-C in prolonging the success of filtration surgery in rabbits and its potential for similar use in humans.